Regular ArticlesThymic Stromal Lymphopoietin Contributes to Myeloid Hyperplasia and Increased Immunoglobulins, But Not Epidermal Hyperplasia, in RabGEF1-Deficient Mice
Cited by (0)
Supported by United States Public Health Service grants (S.J.G.) AI23990, AI070813, and CA72074. C.H.S. was supported by the CBNU funds for overseas research.
Supplemental material for this article can be found on http://ajp.amjpathol.org.
S.J.G. occasionally consults for companies that sell and/or are developing agents to treat allergic disorders, including Amgen Inc., Genentech, and Novartis and is a member of the Scientific Advisory Board of Tunitas Therapeutics, which is developing protein therapeutics for the treatment of allergic diseases.
Current address of C.-C.C.: City of Hope Medical Center, Stem Cell and Leukemia Research, Duarte, California; of C.H.S.: Department of Anatomy, Chonbuk National University Medical School, Jeonju, Korea.